Novel Transmission-Blocking Antimalarials Identified by High-Throughput Screening of Plasmodium berghei Ookluc
Antimicrobial Agents and Chemotherapy · 2023
DOI: 10.1128/aac.01465-22 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von Juliana Calit und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Antimalarials, Malaria, Malaria, Vivax, Culicidae. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Fundação de Amparo à Pesquisa do Estado de São Paulo, HHS | NIH | National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Safe and effective malaria transmission-blocking chemotherapeutics would allow a community-level approach to malaria control and eradication efforts by targeting the mosquito sexual stage of the parasite life cycle. However, only a single drug, primaquine, is currently approved for use in reducing transmission, and drug toxicity limits its widespread implementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, São Paulo, Brazil.
- Plataforma de Produção e Infecção de Vetores da Malária-PIVEM, Laboratório de Entomologia, Fundação Oswaldo Cruz-Fiocruz Rondônia, Porto Velho, Rondônia, Brazil.
- Programa de Pós-graduação em Biologia Experimental, Universidade Federal de Rondônia/Fiocruz Rondônia, Porto Velho, Rondônia, Brazil.
- Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.
- Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, USA.
ORCID-Profile: Anton Simeonov, Richard T Eastman, Daniel Y Bargieri
Förderung
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- HHS | NIH | National Center for Advancing Translational Sciences
- Instituto Serrapilheira
- International Centers of Excellence for Malaria Research
- Bill and Melinda Gates Foundation
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Calit, J., Araújo, J. E., Deng, B., Miura, K., Gaitán, X. A., Araújo, M. D. S., Medeiros, J. F., Long, C. A., Simeonov, A., Eastman, R. T., & Bargieri, D. Y. (2023). Novel Transmission-Blocking Antimalarials Identified by High-Throughput Screening of Plasmodium berghei Ookluc. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01465-22
Vancouver
Calit J, Araújo JE, Deng B, Miura K, Gaitán XA, Araújo MDS, et al. Novel Transmission-Blocking Antimalarials Identified by High-Throughput Screening of Plasmodium berghei Ookluc. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.01465-22
BibTeX
@article{Calit2023,
author = {Calit, Juliana and Araújo, Jessica E and Deng, Bingbing and Miura, Kazutoyo and Gaitán, Xiomara A and Araújo, Maisa da Silva and Medeiros, Jansen F and Long, Carole A and Simeonov, Anton and Eastman, Richard T and Bargieri, Daniel Y},
title = {Novel Transmission-Blocking Antimalarials Identified by High-Throughput Screening of Plasmodium berghei Ookluc},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2023},
doi = {10.1128/aac.01465-22}
}
EUVIMED